On November 9, 2021 Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, reported that company management will participate at the following upcoming investor conferences in November (Press release, Jounce Therapeutics, NOV 9, 2021, View Source [SID1234594864]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

5th Annual Cowen IO Next Summit: Fireside chat on Monday, November 15, 2021 at 10:45 a.m. ET.
33rd Annual Piper Sandler Healthcare Conference: Fireside chat available for on-demand viewing starting Monday, November 22, 2021 at 10:00 a.m. ET.
Webcasts of each fireside chat will be available by visiting "Events and Presentations" in the Investors and Media section of Jounce’s website at www.jouncetx.com. A replay of the webcasts will be archived for 30 days following the presentation.